Pricing Log in Create free account
Saturday 17 October 2026 Export ILMN’s income statement to Excel — free account

Illumina, Inc.

ILMN Healthcare Diagnostics & Research

Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024. In the quarter to June 2026, revenue grew 9.44%, EPS fell 8.05%, free cash flow fell 18.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

262.03 5.90 −2.20%
Market cap
$40.5B
P/E
48.4×
Fwd P/E
34.7×
Dividend yield
—
F-score
8/9
Altman Z
4.39
Beneish M
−2.51
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Illumina, Inc. (ILMN) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, Illumina, Inc. (ILMN) trades at a price to free cash flow of 43.2×. Over the past ten years it has ranged from 0.0× (September 2023) to 868× (August 2022); the current reading is higher than 32% of that period. That is above the Diagnostics & Research industry median of 35.8× and above the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 22.2× (26.15%)
FY2024 30.1× (60.07%)
FY2023 75.3× —
FY2022 0.0× —
FY2021 171× 184.32%
FY2020 60.3× 5.31%
FY2019 57.2× 11.14%
FY2018 51.5× (10.68%)
FY2017 57.6× 56.07%
FY2016 36.9× (17.18%)

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 29.0× 47.39%
Mar 2026 19.7× (11.40%)
Dec 2025 22.2× 50.45%
Sep 2025 14.8× 0.06%
42 more quarters

Against its own ten years

Low 0.0× High 868×
Ten-year median 54.3×
Current reading's percentile 32

Price to free cash flow against peers

Company Price to free cash flow
DGX Quest Diagnostics Incorporated compare 19.3×
IQV IQVIA Holdings Inc. compare 19.6×
LH Labcorp Holdings Inc. compare 25.2×
IDXX IDEXX Laboratories, Inc. compare 35.8×
MTD Mettler-Toledo International, Inc. compare 37.8×
A Agilent Technologies, Inc. compare 38.4×
ILMN Illumina, Inc. 43.2×
WAT Waters Corporation compare 117×
NTRA Natera, Inc. compare 667×
Diagnostics & Research industry median 35.8×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on ILMN